These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1318512)

  • 21. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
    Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
    Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased platelet 3H-imipramine binding in Down's syndrome.
    Tang SW; Berg JM; Bruni J; Davis A
    Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of seasonal variation in platelet [3H]imipramine binding in humans.
    Galzin AM; Lôo H; Sechter D; Langer SZ
    Biol Psychiatry; 1986 Aug; 21(10):876-82. PubMed ID: 3017462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
    Friedl W; Propping P; Weck B
    Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclasses of platelet 3H-imipramine binding sites.
    DeMet EM; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):293-302. PubMed ID: 1963692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors.
    Tang SW; Cheung S; Strijewski A; Chudzik J; Helmeste D
    Psychiatry Res; 1990 Nov; 34(2):205-12. PubMed ID: 1962863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 32. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 33. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes.
    Rojansky N; Halbreich U; Zander K; Barkai A; Goldstein S
    Gynecol Obstet Invest; 1991; 31(3):146-52. PubMed ID: 1649111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients.
    Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H
    Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT.
    Tyrer SP; Marshall EF; Griffiths HW
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):797-805. PubMed ID: 1963498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.
    Suranyi-Cadotte BE; Gauthier S; Lafaille F; DeFlores S; Dam TV; Nair NP; Quirion R
    Life Sci; 1985 Dec; 37(24):2305-11. PubMed ID: 2999549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple [3H]imipramine binding sites in brains of male and female Fawn-Hooded and Long-Evans rats.
    Ieni JR; Tobach E; Zukin SR; Barr GA; Van Praag HM
    Eur J Pharmacol; 1985 Jun; 112(2):261-4. PubMed ID: 2992999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.